Additionally, intervention in the RhoA/ROCK2 signaling pathway via pharmacological approaches and genetic modification attenuates the phosphorylation of radixin, thereby mitigating cognitive impairments induced by sevoflurane. The gene discussed is ROCK2; the disease is Cognitive impairment.